Last updated on November 2017

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease


Brief description of study

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Detailed Study Description

The purpose of this study is to evaluate itacitinib or placebo in combination with corticosteroids as first-line treatment of participants with Grade II to IV acute graft-versus-host disease (aGVHD).

Clinical Study Identifier: TX151481

Contact Investigators or Research Sites near you

Start Over

Onclology Hematology in Cincinnati

Onclology Hematology in Cincinnati
Cincinnati, OH USA
  Connect »

Sarah Cannon Research Institute, LLC

Sarah Cannon Research Institute, LLC
Nashville, TN USA
  Connect »

Colorado Blood Cancer Institute

Colorado Blood Cancer Institute
Denver, CO USA
  Connect »

University of Chicago

University of Chicago
Chicago, IL USA
  Connect »

Massachusetts General Hospital

Massachusetts General Hospital
Boston, MA USA
  Connect »

Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center
Boston, MA USA
  Connect »

Texas Transplant Institute

Texas Transplant Institute
San Antonio, TX USA
  Connect »

Tulane University Medical Center

Tulane University Medical Center
New Orleans, LA USA
  Connect »

University of Mississippi Medical Center

University of Mississippi Medical Center
Jackson, MS USA
  Connect »

Stony Brook University

Stony Brook University
Stony Brook, NY USA
  Connect »

UPMC Hillman Cancer Center

UPMC Hillman Cancer Center
Pittsburgh, PA USA
  Connect »

Incyte Corporation Call Center (US)

University of California, Los Angeles (UCLA) - Medical Center
Los Angeles, CA United States
  Connect »

Incyte Corporation Call Center (US)

Indiana Blood and Marrow Transplant
Indianapolis, IN United States
  Connect »

Incyte Corporation Call Center (US)

Barbara Ann Karmanos Cancer Institute
Detroit, MI United States
  Connect »

Incyte Corporation Call Center (US)

Washington University School of Medicine
Saint Louis, MO United States
  Connect »

Incyte Corporation Call Center (US)

Rutgers Cancer Institute of New Jersey
New Brunswick, NJ United States
  Connect »

Incyte Corporation Call Center (US)

Thomas Jefferson University
Philadelphia, PA United States
  Connect »

Incyte Corporation Call Center (US)

Hospital Universitario Vall d'Hebron
Barcelona, Spain
  Connect »

Incyte Corporation Call Center (US)

Hospital Universitario Ramon y Cajal
Madrid, Spain
  Connect »

Incyte Corporation Call Center (US)

Hospital Universitario La Paz
Madrid, Spain
  Connect »

University of Kansas Cancer Center

University of Kansas Cancer Center
Kansas City, KS United States
  Connect »

Hackensack University Medical Center

Hackensack University Medical Center
Hackensack, NJ USA
  Connect »

Ordensklinikum Linz GmbH Elisabethinen

Ordensklinikum Linz GmbH Elisabethinen
Linz, Austria
  Connect »

Centrum Onkologii- Instytut w Gliwicach

Centrum Onkologii- Instytut w Gliwicach
Gliwice, Poland
  Connect »